Ylikotila P, Ketola RA, Timonen S, Malm H, Ruuskanen JO. Early pregnancy cerebral venous thrombosis and status epilepticus treated with levetiracetam and lacosamide throughout pregnancy. Reprod Toxicol. 2015;57:204-6.

Johannessen SI, Helde G, Brodtkorb E. Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia 2005;46(5):775-777

Tomson T, Palm R, Kallen K, Ben-Menachem E, Soderfeldt B, Danielsson B et al. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Epilepsia 2007;48(6):1111-1116

Paret N, Gouraud A, Bernard N, Burel M, Cottin J, Descotes J et al. Long-term follow-up of infants exposed to levetiracetam during breastfeeding: Comparison to a control group. Birth Defects Res A Clin Mol Teratol 2014;100:537-538. Abstract.

Krämer G, Hösli I, Glanzmann R, Holzgreve W. Levetiracetam accumulation in human breast milk. Epilepsia 2002;43[Suppl 7]:105

Greenhill L, Betts, Yarrow H, Patsalos P. Breast milk levels of levetiracetam after delivery. Epilepsia 2004;45((suppl 7)):230. Abstract.

Birnbaum AK, Meador KJ, Karanam A, Brown C, May RC, Gerard EE et al. Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy. JAMA Neurol. 2020;77(4):441-450.

Kacirova I, Grundmann M, Brozmanova H. Umbilical Cord, Maternal Milk, and Breastfed Infant Levetiracetam Concentrations Monitoring at Delivery and during Early Postpartum Period. Pharmaceutics. 2021;13(3):1-12.

Lattanzi S, Cagnetti C, Foschi N, Provinciali L, Silvestrini M. Lacosamide during pregnancy and breastfeeding. Neurol Neurochir Pol. 2017;51(3):266-269.

Dinavitser N, Kohn E, Berlin M, Brandriss N, Bar-Chaim A, Keidar R et al. Levetiracetam in lactation: How much is excreted into human breast milk?. Br J Clin Pharmacol. 2021.